Determinants of Sleep Quality in Spanish Population (SSQD Study)

Sponsor
University of Salamanca (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05324267
Collaborator
Gerencia Regional de Salud de Castilla y León (Other), Instituto de Investigación Biomédica de Salamanca (Other)
500
12

Study Details

Study Description

Brief Summary

Introduction: Sleep disorders are a growing concern for public health, being related, among others, to an increased risk of cardiovascular diseases or poorer cognitive functioning. In addition, these might have a possible impact on aspects related to personal motivation and quality of life. However, few studies have analyzed the possible determinants of sleep quality in the adult population as a whole, establishing patterns based on these.

Objective: To evaluate the determinants of sleep quality in a representative sample of the general adult population aged 25 to 65 years old and to establish patterns of sleep quality based on lifestyles, psychological factors, morbidities and biological markers.

Methodology:

Design: This is a descriptive observational, cross-sectional study that will include a representative sample of 500 people aged 25 to 65 years old from the city of Salamanca (Spain) selected by random sampling stratified by age and sex.

Study variables: A visit lasting approximately 90 minutes will be carried out. The determinants of sleep quality will be assessed using both objective and self-reported methods. Variables related to life styles will be assessed: physical activity, diet and toxic habits including tobacco smoking or alcohol use. Morbidity data will also be collected, and psychological factors such as anxiety will also be assessed. Serum melatonin levels will be determined as a biological marker related to sleep quality.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Determinants of Sleep Quality in Spanish Population: SSQD Study
    Anticipated Study Start Date :
    Jun 1, 2022
    Anticipated Primary Completion Date :
    Mar 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Sleep quality [Baseline]

      Measured by accelerometer (Actigraph GT3X). This device reports Total Sleep Time (TST) measured in minutes.

    2. Sleep quality [Baseline]

      Measured by the Pittsburgh Sleep Quality Index (PSQI). Possible scores on the PSQI range from 0 (no difficulty) to 21 (severe difficulties in all areas).

    Secondary Outcome Measures

    1. Physical activity [Baseline]

      Measured by accelerometer (Actigraph GT3X). This device reports physical activity measured in steps per hour.

    2. Diet [Baseline]

      Measured by the Mediterranean Diet Adherence Screener (MEDAS). Possible scores range from 0 (lower adherence) to 14 (higher adherence).

    3. Tobacco smoking [Baseline]

      Measured by the Fagerström Test for Nicotine Dependence. This six-item questionnaire generates test scores ranging from 0 to 10, with higher scores indicating greater nicotine dependence.

    4. Alcohol use [Baseline]

      Measured by the Alcohol Use Disorders Identification Test (AUDIT). Possible scores range from 0 to 40. An AUDIT score of 8 or more indicates hazardous or harmful alcohol use; a score of less than 8 indicates non-hazardous consumption.

    5. Anxiety [Baseline]

      Measured by the Generalized Anxiety Disorder (GAD-7) questionnaire. Possible scores range from 0 to 21. Increasing scores indicate higher levels of anxiety.

    6. Serum melatonin levels [Baseline]

      Serum melatonin levels (measured in pg/ml) will be determined by high performance liquid chromatography-triple quadrupole mass spectrometry (HPLC-MS/MS triple quadrupole).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 25-65 years old

    • Sign the informed consent

    Exclusion Criteria:
    • Patients with terminal disease

    • Any clinical condition that would interfere with study procedures

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Salamanca
    • Gerencia Regional de Salud de Castilla y León
    • Instituto de Investigación Biomédica de Salamanca

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    José Ignacio Recio Rodriguez, PhD, Associate Professor, University of Salamanca
    ClinicalTrials.gov Identifier:
    NCT05324267
    Other Study ID Numbers:
    • GRS 2320/A/21
    First Posted:
    Apr 12, 2022
    Last Update Posted:
    Apr 12, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by José Ignacio Recio Rodriguez, PhD, Associate Professor, University of Salamanca

    Study Results

    No Results Posted as of Apr 12, 2022